Delayed or wrong Parkinson's diagnosis impacts individuals' treatment and research toward new therapies. Investigators are working to validate biological measures of disease that could help confirm diagnosis and identify Parkinson's earlier in the disease process.
"Biomarkers are tools to understand not only who has Parkinson’s and who doesn’t but also to track the symptoms of Parkinson’s as they progress and to understand whether a particular drug treatment is working or not," says Samantha Hutten, PhD, MJFF senior associate director of research programs, in our latest podcast.
Join our webinar this Thursday, March 17 at 12 p.m. ET/9 a.m. PT to hear more from Dr. Hutten and other panelists on the search for a Parkinson's diagnostic tool.
Watch archived webinars on topics from exercise and complementary medicine to stem cells and sexual dysfunction.
